Efficiency and safety of subconjunctival injection of anti-VEGF agent – bevacizumab – in treating dry eye

Xiaodan JiangDepartment of Ophthalmology, Peking University Third Hospital, Beijing, People’s Republic of China

Huibin LvDepartment of Ophthalmology, Peking University Third Hospital, Beijing, People’s Republic of China

Weiqiang QiuDepartment of Ophthalmology, Peking University Third Hospital, Beijing, People’s Republic of China

Ziyuan LiuDepartment of Ophthalmology, Peking University Third Hospital, Beijing, People’s Republic of China

Xuemin LiDepartment of Ophthalmology, Peking University Third Hospital, Beijing, People’s Republic of ChinaCorrespondence[email protected]

Wei WangDepartment of Ophthalmology, Peking University Third Hospital, Beijing, People’s Republic of China

Pages 3043-3050 | Published online: 12 Jun 2015

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

MassingaleMLLiXVallabhajosyulaMChenDWeiYAsbellPAAnalysis of inflammatory cytokines in the tears of dry eye patientsCornea2009281023102719724208
PubMed Web of Science ®Google Scholar
CalongeMEnríquez-de-SalamancaADieboldYDry eye disease as an inflammatory disorderOcul Immunol Inflamm201018424425320482396
PubMed Web of Science ®Google Scholar
BronAJTiffanyJMYokoiNGouveiaSMUsing osmolarity to diagnose dry eye: a compartmental hypothesis and review of our assumptionsAdv Exp Med Biol20025061087109512614035
PubMed Web of Science ®Google Scholar
LiDQChenZSongXJLuoLPflugfelderSCStimulation of matrix metalloproteinases by hyperosmolarity via a JNK pathway in human corneal epithelial cellsInvest Ophthalmol Vis Sci2004454302431115557436
PubMed Web of Science ®Google Scholar
YehSSongXJFarleyWLiDQSternMEPflugfelderSCApoptosis of ocular surface cells in experimentally induced dry eyeInvest Ophthalmol Vis Sci20034412412912506064
PubMed Web of Science ®Google Scholar
SemeraroFMorescalchiFDuseSParmeggianiFGambicortiECostagliolaCAflibercept in wet AMD: specific role and optimal useDrug Des Devel Ther20137711722
PubMed Web of Science ®Google Scholar
Abu El-AsrarAMAl-MansouriSTabbaraKFMissottenLGeboesKImmunopathogenesis of conjunctival remodelling in vernal keratoconjunctivitisEye (Lond)200620717915746957
PubMed Web of Science ®Google Scholar
YooSAKwokSKKimWUProinflammatory role of vascular endothelial growth factor in the pathogenesis of rheumatoid arthritis: prospects for therapeutic interventionMediators Inflamm2008200812987319223981
PubMed Web of Science ®Google Scholar
FerraraNGerberH-PLeCouterJThe biology of VEGF and its receptorsNat Med2003966967612778165
PubMed Web of Science ®Google Scholar
SandlerAGrayRPerryMCPaclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancerN Engl J Med20063552542255017167137
PubMed Web of Science ®Google Scholar
FoulksGNReport of the International Dry Eye WorkShop (DEWS)Ocul Surf2007561204
Web of Science ®Google Scholar
OzcuraFAydinSHelvaciMROcular surface disease index for the diagnosis of dry eye syndromeOcul Immunol Inflamm200715538939317972223
PubMed Web of Science ®Google Scholar
BayarSAKucukerdonmezCOnerOAkovaYASubconjunctival bevacizumab in the impending recurrent pterygiaInt Ophthalmol20143454154724026871
PubMed Web of Science ®Google Scholar
LiXMHuLHuJWangWInvestigation of dry eye disease and analysis of the pathogenic factors in patients after cataractsurgeryCornea200726162017198008
PubMed Web of Science ®Google Scholar
CafferyBEJosephsonJECorneal staining after sequential instillations of fluorescein over 30 daysOptom Vis Sci1991684674691716353
PubMed Web of Science ®Google Scholar
ThomasMLSzetoVRGanCMPolseKASequential staining: the effects of sodium fluorescein, osmolarity, and pH on human corneal epitheliumOptom Vis Sci1997742072109200164
PubMed Web of Science ®Google Scholar
YamaguchiMKutsunaMUnoTZhengXKodamaTOhashiYMarx line: fluorescein staining line on the inner lid as indicator of meibomian gland functionAm J Ophthalmol200614166967516564801
PubMed Web of Science ®Google Scholar
BenitoMJGonzález-GarcíaMJTesónMIntra-and inter-day variation of cytokines and chemokines in tears of healthy subjectsExp Eye Res2014120434924412438
PubMed Web of Science ®Google Scholar
GoyalSChauhanSKDanaRBlockade of prolymphangiogenic vascular endothelial growth factor C in dry eye diseaseArch Ophthalmol2012130848921911653
PubMedGoogle Scholar
WangXMHamzaMWuTXDionneRAUpregulation of IL-6, IL-8 and CCL2 gene expression after acute inflammation: correlation to clinical painPain200914227528319233564
PubMed Web of Science ®Google Scholar
LinJLiGDenXVEGF and its receptor-2 involved in neuropathic pain transmission mediated by P2X2(/)3 receptor of primary sensory neuronsBrain Res Bull20108328429120705122
PubMed Web of Science ®Google Scholar
EnkvetchakulOThanathaneeORangsinRLekhanontKSuwan-ApichonOA randomized controlled trial of intralesional bevacizumab injection on primary pterygium: preliminaryresultsCornea2011301213121821915047
PubMed Web of Science ®Google Scholar
PuinhasASampaioPCastanheiraEMReal OliveiraMELiraMComparison of IgA, TNF-α and surface tension of the tear film in two different times of the dayCont Lens Anterior Eye20133614014523290099
PubMed Web of Science ®Google Scholar
Enríquez-de-SalamancaACastellanosESternMETear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye diseaseMol Vis20101686287320508732
PubMed Web of Science ®Google Scholar
MarsovszkyLReschMDNémethJIn vivo confocal microscopic evaluation of corneal Langerhans cell density, and distribution and evaluation of dry eye in rheumatoid arthritisInnate Immun20131934835423204037
PubMed Web of Science ®Google Scholar
Contreras-RuizLGhosh-MitraAShatosMADarttDAMasliSModulation of conjunctival goblet cell function by inflammatory cytokinesMediators Inflamm2013201363681224453426
PubMed Web of Science ®Google Scholar
JoussenAMPoulakiVMitsiadesNVEGF-dependent conjunctivalization of the corneal surfaceInvest Ophthalmol Vis Sci20034411712312506063
PubMed Web of Science ®Google Scholar
MessengerWBBeardsleyRMFlaxelCJFluocinolone acetonide intravitreal implant for the treatment of diabetic macular edemaDrug Des Devel Ther20137425434
PubMed Web of Science ®Google Scholar

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Efficiency and safety of subconjunctival injection of anti-VEGF agent – bevacizumab – in treating dry eye

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Efficiency and safety of subconjunctival injection of anti-VEGF agent – bevacizumab – in treating dry eye

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date